Publicaciones en las que colabora con P. Coto-Segura (54)

2015

  1. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort

    Journal of Dermatological Science, Vol. 80, Núm. 2, pp. 111-115

  2. CDKAL1 gene variants affect the anti-TNF response among Psoriasis patients

    International Immunopharmacology, Vol. 29, Núm. 2, pp. 947-949

  3. Complementariedad inter-grados en la educación superior: construyendo espacio comunes entre los grados de lengua española y sus literaturas y medicina

    Innovación en la Educación Superior: desafíos y propuestas (Oviedo, Ediciones de la Universidad de Oviedo, Servicio de Publicaciones, D.L. 2015), pp. 609-613

  4. Cutaneous spread of primary neuroendocrine breast carcinoma with apocrine differentiation

    Journal of the European Academy of Dermatology and Venereology

  5. Efficacy of adalimumab in the treatment of moderate-to-severe psoriasis: A retrospective study of 100 patients in daily practice

    Journal of Dermatological Treatment, Vol. 26, Núm. 1, pp. 49-53

  6. Merkel cell carcinoma and Merkel cell polyomavirus: A systematic review and meta-analysis

    British Journal of Dermatology, Vol. 173, Núm. 1, pp. 42-49

  7. Psoriasis vulgaris with or without arthritis and independent of disease severity or duration is a risk factor for hypercholesterolemia

    Dermatology, Vol. 230, Núm. 2, pp. 170-176

  8. The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients

    Pharmacogenetics and Genomics, Vol. 25, Núm. 6, pp. 313-316

  9. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients

    Archives of Dermatological Research, Vol. 307, Núm. 5, pp. 405-412

2012

  1. Actitud ante un paciente con cara roja aguda

    Dermatología en urgencias: guía práctica (Editorial Médica Panamericana), pp. 54-60

  2. Common European mitochondrial haplogroups in the risk for psoriasis and psoriatic arthritis

    Genetic Testing and Molecular Biomarkers, Vol. 16, Núm. 6, pp. 621-623

  3. Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor

    Australasian Journal of Dermatology, Vol. 53, Núm. 1, pp. 70-72

  4. Psoriasis and hypertension: A case-control study

    Journal of the European Academy of Dermatology and Venereology, Vol. 26, Núm. 6, pp. 785-788

  5. Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population

    Australasian Journal of Dermatology, Vol. 53, Núm. 2, pp. 128-130